A carregar...
Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
BACKGROUND: Tigecycline has potential utility in the treatment of complex polymicrobial infections or those caused by MDR organisms in the ambulatory care setting owing to its breadth of antimicrobial coverage. Whilst licensed for twice-daily IV administration, its long half-life permits once-daily...
Na minha lista:
| Publicado no: | JAC Antimicrob Resist |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8210309/ https://ncbi.nlm.nih.gov/pubmed/34222958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jacamr/dlz085 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|